SCHEMBL3712643

SCHEMBL3712643

CCCNC(=O)N1CCC(CSc2ncc(C(C)(C)c3ccc(Cl)c(Cl)c3)n2-c2ccc(F)c(OC)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 17/20 0.43
FNTA P49354 2/20 0.39
FNTB P49356 2/20 0.39
ALK Q9UM73 1/20 0.35
NR1H4 Q96RI1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL604136 0.90 GPBAR1 (0.43) GPBAR1NR1H4
SCHEMBL15383100 0.82 GPBAR1 (0.52) GPBAR1
SCHEMBL601952 0.80 GPBAR1 (0.43) GPBAR1NR1H4
SCHEMBL601931 0.78 GPBAR1 (0.53) GPBAR1NR1H4
SCHEMBL600927 0.77 GPBAR1 (0.56) GPBAR1
SCHEMBL602418 0.77 GPBAR1 (0.52) GPBAR1NR1H4
SCHEMBL601616 0.76 GPBAR1 (0.46) GPBAR1
SCHEMBL603581 0.76 GPBAR1 (0.46) GPBAR1
SCHEMBL601478 0.76 GPBAR1 (0.51) GPBAR1
SCHEMBL605231 0.76 GPBAR1 (0.51) GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396304-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY Exelixis, Inc. (US) 2011-12-21 EP claimed
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO claimed